Schobel Alexander Mark (CIK 0001406836)

Latest company ownership

AQST - Aquestive Therapeutics, Inc.
Role: Chief Innovation/Tech Officer
Shares held
980,726
Last filed at
Oct 2, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 9, 2024 Oct 2, 2024 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 48.8 -9,645 -0.97% ✗ $47.1K
Mar 15, 2024 Mar 19, 2024 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 35.0 -50,000 -4.83% ✓ $300K
Mar 8, 2024 Mar 12, 2024 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 41.3 -30,895 -2.90% ✓ $158.5K
Jun 8, 2022 Jun 10, 2022 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Buy 86.3 +45,871 5.48% ✗ $44K
Feb 9, 2021 Feb 10, 2021 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 37.5 -35,000 -4.01% ✓ $236.3K
Feb 8, 2021 Feb 9, 2021 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 35.0 -40,792 -4.47% ✓ $265.1K
Jun 30, 2020 Jul 2, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -94 -0.01% ✗ $456.8
May 31, 2020 Jun 2, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 51.3 -4,132 -0.45% ✗ $20.1K
May 8, 2020 May 11, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 37.5 -40,000 -4.25% ✓ $200K
Apr 14, 2020 May 4, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 26.3 -80,000 -7.83% ✓ $308K
Apr 29, 2020 May 1, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 37.5 -40,000 -3.77% ✓ $180K
Mar 31, 2020 Apr 2, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -97 -0.01% ✗ $212.4
Feb 29, 2020 Mar 3, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 51.3 -5,066 -0.47% ✗ $18.9K
Dec 31, 2019 Feb 26, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -147 -0.01% ✗ $855.5
Nov 30, 2019 Feb 26, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 32.5 -6,544 -0.62% ✗ $51K
Dec 31, 2019 Jan 2, 2020 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -329 -0.03% ✗ $1.9K
Nov 30, 2019 Dec 2, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 42.5 -14,572 -1.38% ✗ $113.5K
Sep 30, 2019 Oct 2, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -145 -0.01% ✗ $461.1
Aug 31, 2019 Sep 3, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 48.8 -6,460 -0.61% ✗ $24.5K
Jun 30, 2019 Jul 2, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -149 -0.01% ✗ $625.8
May 31, 2019 Jun 3, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 48.8 -6,591 -0.63% ✗ $24.5K
Mar 31, 2019 Apr 1, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -263 -0.03% ✗ $1.8K
Feb 28, 2019 Mar 1, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 45.0 -6,721 -0.65% ✗ $54.1K
Dec 31, 2018 Jan 3, 2019 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -162 -0.02% ✗ $1K
Dec 10, 2018 Dec 11, 2018 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Buy 55.0 +1,000 0.10% ✗ $7.8K
Dec 6, 2018 Dec 10, 2018 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Buy 56.3 +2,000 0.20% ✗ $17.4K
Nov 30, 2018 Dec 4, 2018 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 32.5 -7,177 -0.70% ✗ $61.7K
Nov 21, 2018 Nov 26, 2018 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Buy 56.3 +1,000 0.10% ✗ $10.3K
Sep 30, 2018 Oct 2, 2018 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 52.5 -162 -0.02% ✗ $2.8K
Aug 31, 2018 Sep 5, 2018 Aquestive Therapeutics, Inc. Chief Innovation/Tech Officer Sell 32.5 -6,510 -0.64% ✗ $117.2K